ID   AT1A3_HUMAN             Reviewed;        1013 AA.
AC   P13637; B7Z2T0; B7Z401; F5H6J6; Q16732; Q16735; Q969K5;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   10-MAY-2017, entry version 193.
DE   RecName: Full=Sodium/potassium-transporting ATPase subunit alpha-3;
DE            Short=Na(+)/K(+) ATPase alpha-3 subunit;
DE            EC=3.6.3.9;
DE   AltName: Full=Na(+)/K(+) ATPase alpha(III) subunit;
DE   AltName: Full=Sodium pump subunit alpha-3;
GN   Name=ATP1A3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=2838329; DOI=10.1016/0014-5793(88)81361-9;
RA   Ovchinnikov Y.A., Monastyrskaya G.S., Broude N.E., Ushkaryov Y.A.,
RA   Melkov A.M., Smirnov Y.V., Malyshev I.V., Allikmets R.L.,
RA   Kostina M.B., Dulubova I.E., Kiyatkin N.I., Grishin A.V.,
RA   Modyanov N.N., Sverdlov E.D.;
RT   "Family of human Na+, K+-ATPase genes. Structure of the gene for the
RT   catalytic subunit (alpha III-form) and its relationship with
RT   structural features of the protein.";
RL   FEBS Lett. 233:87-94(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=2834163;
RA   Sverdlov E.D., Monastyrskaya G.S., Broude N.E., Ushkarev Y.A.,
RA   Melkov A.M., Smirnov Y.V., Malyshev I.V., Allikmets R.L.,
RA   Kostina M.B., Dulubova I.E., Kiyatkin N.I., Grishin A.V.,
RA   Modyanov N.N., Ovchinnikov Y.A.;
RT   "Family of human Na(+),K(+)-ATPase genes. Structure of the gene of
RT   isoform alpha-III.";
RL   Dokl. Akad. Nauk SSSR 297:1488-1494(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Brain, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 120-387; 494-538 AND 545-1013.
RX   PubMed=3030810; DOI=10.1016/0014-5793(87)81467-9;
RA   Ovchinnikov Y.A., Monastyrskaya G.S., Broude N.E., Allikmets R.L.,
RA   Ushkaryov Y.A., Melkov A.M., Smirnov Y.V., Malyshev I.V.,
RA   Dulubova I.E., Petrukhin K.E., Gryshin A.V., Sverdlov V.E.,
RA   Kiyatkin N.I., Kostina M.B., Modyanov N.N., Sverdlov E.D.;
RT   "The family of human Na+,K+-ATPase genes. A partial nucleotide
RT   sequence related to the alpha-subunit.";
RL   FEBS Lett. 213:73-80(1987).
RN   [7]
RP   ERRATUM.
RA   Ovchinnikov Y.A., Monastyrskaya G.S., Broude N.E., Allikmets R.L.,
RA   Ushkaryov Y.A., Melkov A.M., Smirnov Y.V., Malyshev I.V.,
RA   Dulubova I.E., Petrukhin K.E., Gryshin A.V., Sverdlov V.E.,
RA   Kiyatkin N.I., Kostina M.B., Modyanov N.N., Sverdlov E.D.;
RL   FEBS Lett. 214:375-375(1987).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 243-434.
RX   PubMed=3036582; DOI=10.1016/0014-5793(87)80677-4;
RA   Sverdlov E.D., Monastyrskaya G.S., Broude N.E., Ushkaryov Y.A.,
RA   Allikmets R.L., Melkov A.M., Smirnov Y.V., Malyshev I.V.,
RA   Dulubova I.E., Petrukhin K.E., Gryshin A.V., Kiyatkin N.I.,
RA   Kostina M.B., Sverdlov V.E., Modyanov N.N., Ovchinnikov Y.A.;
RT   "The family of human Na+,K+-ATPase genes. No less than five genes
RT   and/or pseudogenes related to the alpha-subunit.";
RL   FEBS Lett. 217:275-278(1987).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=7711835; DOI=10.3109/09687689409160435;
RA   Hundal H.S., Maxwell D.L., Ahmed A., Darakhshan F., Mitsumoto Y.,
RA   Klip A.;
RT   "Subcellular distribution and immunocytochemical localization of Na,K-
RT   ATPase subunit isoforms in human skeletal muscle.";
RL   Mol. Membr. Biol. 11:255-262(1994).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   VARIANTS DYT12 THR-274; LYS-277; MET-613; SER-758; LEU-780 AND
RP   TYR-801.
RX   PubMed=15260953; DOI=10.1016/j.neuron.2004.06.028;
RA   de Carvalho Aguiar P., Sweadner K.J., Penniston J.T., Zaremba J.,
RA   Liu L., Caton M., Linazasoro G., Borg M., Tijssen M.A.J.,
RA   Bressman S.B., Dobyns W.B., Brashear A., Ozelius L.J.;
RT   "Mutations in the Na(+)/K(+)-ATPase alpha-3 gene ATP1A3 are associated
RT   with rapid-onset dystonia parkinsonism.";
RL   Neuron 43:169-175(2004).
RN   [12]
RP   VARIANT DYT12 TYR-1013 EXT, AND CHARACTERIZATION OF VARIANT DYT12
RP   TYR-1013 EXT.
RX   PubMed=19351654; DOI=10.1093/hmg/ddp170;
RA   Blanco-Arias P., Einholm A.P., Mamsa H., Concheiro C.,
RA   Gutierrez-de-Teran H., Romero J., Toustrup-Jensen M.S., Carracedo A.,
RA   Jen J.C., Vilsen B., Sobrido M.J.;
RT   "A C-terminal mutation of ATP1A3 underscores the crucial role of
RT   sodium affinity in the pathophysiology of rapid-onset dystonia-
RT   parkinsonism.";
RL   Hum. Mol. Genet. 18:2370-2377(2009).
RN   [13]
RP   VARIANT DYT12 ASN-923.
RX   PubMed=19652145; DOI=10.1212/WNL.0b013e3181b04acd;
RA   Anselm I.A., Sweadner K.J., Gollamudi S., Ozelius L.J., Darras B.T.;
RT   "Rapid-onset dystonia-parkinsonism in a child with a novel atp1a3 gene
RT   mutation.";
RL   Neurology 73:400-401(2009).
RN   [14]
RP   VARIANTS AHC2 ASN-274; ASP-322; PRO-371; CYS-755; ARG-772; ILE-773;
RP   ASN-801; LYS-815 AND TYR-923.
RX   PubMed=22850527; DOI=10.1016/S1474-4422(12)70182-5;
RA   Rosewich H., Thiele H., Ohlenbusch A., Maschke U., Altmuller J.,
RA   Frommolt P., Zirn B., Ebinger F., Siemes H., Nurnberg P.,
RA   Brockmann K., Gartner J.;
RT   "Heterozygous de-novo mutations in ATP1A3 in patients with alternating
RT   hemiplegia of childhood: a whole-exome sequencing gene-identification
RT   study.";
RL   Lancet Neurol. 11:764-773(2012).
RN   [15]
RP   VARIANTS AHC2 TYR-137; PHE-137; LEU-140; ASN-220; ASN-274; PHE-333;
RP   SER-755; SER-773; ASN-801; ARG-806; SER-810; PRO-811; LYS-815; VAL-919
RP   DEL; ARG-947; ASP-955 AND TYR-992, AND CHARACTERIZATION OF VARIANTS
RP   AHC2 ASN-801; PRO-811 AND LYS-815.
RX   PubMed=22842232; DOI=10.1038/ng.2358;
RA   Heinzen E.L., Swoboda K.J., Hitomi Y., Gurrieri F., Nicole S.,
RA   de Vries B., Tiziano F.D., Fontaine B., Walley N.M., Heavin S.,
RA   Panagiotakaki E., Neri G., Koelewijn S., Kamphorst J.,
RA   Geilenkirchen M., Pelzer N., Laan L., Haan J., Ferrari M.,
RA   van den Maagdenberg A.M., Zucca C., Bassi M.T., Franchini F.,
RA   Vavassori R., Giannotta M., Gobbi G., Granata T., Nardocci N.,
RA   De Grandis E., Veneselli E., Stagnaro M., Vigevano F., Oechsler C.,
RA   Arzimanoglou A., Ninan M., Neville B., Ebinger F., Fons C.,
RA   Campistol J., Kemlink D., Nevsimalova S., Peeters-Scholte C.,
RA   Casaer P., Casari G., Sange G., Spiel G., Martinelli Boneschi F.,
RA   Schyns T., Crawley F., Poncelin D., Fiori S., Abiusi E., Di Pietro L.,
RA   Sweney M.T., Newcomb T.M., Viollet L., Huff C., Jorde L.B.,
RA   Reyna S.P., Murphy K.J., Shianna K.V., Gumbs C.E., Little L.,
RA   Silver K., Ptacek L.J., Ferrari M.D., Bye A.M., Herkes G.K.,
RA   Whitelaw C.M., Webb D., Lynch B.J., Uldall P., King M.D.,
RA   Scheffer I.E., Sisodiya S.M., Mikati M.A., Goldstein D.B.;
RT   "De novo mutations in ATP1A3 cause alternating hemiplegia of
RT   childhood.";
RL   Nat. Genet. 44:1030-1034(2012).
RN   [16]
RP   VARIANTS AHC2 CYS-755; ASN-801 AND LYS-815.
RX   PubMed=23409136; DOI=10.1371/journal.pone.0056120;
RA   Ishii A., Saito Y., Mitsui J., Ishiura H., Yoshimura J., Arai H.,
RA   Yamashita S., Kimura S., Oguni H., Morishita S., Tsuji S., Sasaki M.,
RA   Hirose S.;
RT   "Identification of ATP1A3 mutations by exome sequencing as the cause
RT   of alternating hemiplegia of childhood in Japanese patients.";
RL   PLoS ONE 8:E56120-E56120(2013).
RN   [17]
RP   INVOLVEMENT IN CAPOS, AND VARIANT CAPOS LYS-818.
RX   PubMed=24468074; DOI=10.1186/1750-1172-9-15;
RA   Demos M.K., van Karnebeek C.D., Ross C.J., Adam S., Shen Y.,
RA   Zhan S.H., Shyr C., Horvath G., Suri M., Fryer A., Jones S.J.,
RA   Friedman J.M.;
RT   "A novel recurrent mutation in ATP1A3 causes CAPOS syndrome.";
RL   Orphanet J. Rare Dis. 9:15-15(2014).
CC   -!- FUNCTION: This is the catalytic component of the active enzyme,
CC       which catalyzes the hydrolysis of ATP coupled with the exchange of
CC       sodium and potassium ions across the plasma membrane. This action
CC       creates the electrochemical gradient of sodium and potassium ions,
CC       providing the energy for active transport of various nutrients.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O + Na(+)(In) + K(+)(Out) = ADP +
CC       phosphate + Na(+)(Out) + K(+)(In).
CC   -!- SUBUNIT: Composed of three subunits: alpha (catalytic), beta and
CC       gamma.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:7711835};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:7711835}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P13637-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P13637-2; Sequence=VSP_046956;
CC       Name=3;
CC         IsoId=P13637-3; Sequence=VSP_046957;
CC   -!- DISEASE: Dystonia 12 (DYT12) [MIM:128235]: An autosomal dominant
CC       dystonia-parkinsonism disorder. Dystonia is defined by the
CC       presence of sustained involuntary muscle contractions, often
CC       leading to abnormal postures. DYT12 patients develop dystonia and
CC       parkinsonism between 15 and 45 years of age. The disease is
CC       characterized by an unusually rapid evolution of signs and
CC       symptoms. The sudden onset of symptoms over hours to a few weeks,
CC       often associated with physical or emotional stress, suggests a
CC       trigger initiating a nervous system insult resulting in permanent
CC       neurologic disability. {ECO:0000269|PubMed:15260953,
CC       ECO:0000269|PubMed:19351654, ECO:0000269|PubMed:19652145}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Alternating hemiplegia of childhood 2 (AHC2)
CC       [MIM:614820]: A rare syndrome of episodic hemi- or quadriplegia
CC       lasting minutes to days. Most cases are accompanied by dystonic
CC       posturing, choreoathetoid movements, nystagmus, other ocular motor
CC       abnormalities, autonomic disturbances, and progressive cognitive
CC       impairment. It is typically distinguished from familial hemiplegic
CC       migraine by infantile onset and high prevalence of associated
CC       neurological deficits that become increasingly obvious with age.
CC       {ECO:0000269|PubMed:22842232, ECO:0000269|PubMed:22850527,
CC       ECO:0000269|PubMed:23409136}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Cerebellar ataxia, areflexia, pes cavus, optic atrophy,
CC       and sensorineural hearing loss (CAPOS) [MIM:601338]: An autosomal
CC       dominant neurologic disorder characterized by relapsing and
CC       partially remitting, early-onset cerebellar ataxia following a
CC       febrile illness. Other features include progressive optic atrophy
CC       and sensorineural hearing loss, generalized hypotonia, areflexia
CC       and pes cavus without evidence of a peripheral neuropathy on
CC       neurophysiological studies. {ECO:0000269|PubMed:24468074}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type)
CC       (TC 3.A.3) family. Type IIC subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M37457; AAA51798.1; -; Genomic_DNA.
DR   EMBL; M37436; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37437; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37438; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37462; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37439; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37440; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37441; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37442; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37443; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37444; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37445; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37447; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37448; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37449; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37450; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37451; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37452; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37453; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37454; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37455; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; M37456; AAA51798.1; JOINED; Genomic_DNA.
DR   EMBL; X12910; CAA31390.1; -; Genomic_DNA.
DR   EMBL; X12911; CAA31390.1; JOINED; Genomic_DNA.
DR   EMBL; X12912; CAA31390.1; JOINED; Genomic_DNA.
DR   EMBL; X12913; CAA31390.1; JOINED; Genomic_DNA.
DR   EMBL; X12914; CAA31390.1; JOINED; Genomic_DNA.
DR   EMBL; X12915; CAA31390.1; JOINED; Genomic_DNA.
DR   EMBL; X12916; CAA31390.1; JOINED; Genomic_DNA.
DR   EMBL; X12917; CAA31390.1; JOINED; Genomic_DNA.
DR   EMBL; X12919; CAA31390.1; JOINED; Genomic_DNA.
DR   EMBL; X12920; CAA31390.1; JOINED; Genomic_DNA.
DR   EMBL; X12921; CAA31390.1; JOINED; Genomic_DNA.
DR   EMBL; X12922; CAA31390.1; JOINED; Genomic_DNA.
DR   EMBL; X12923; CAA31390.1; JOINED; Genomic_DNA.
DR   EMBL; AK295078; BAH11966.1; -; mRNA.
DR   EMBL; AK296557; BAH12387.1; -; mRNA.
DR   EMBL; AC010616; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC009282; AAH09282.1; -; mRNA.
DR   EMBL; BC009394; AAH09394.1; -; mRNA.
DR   EMBL; BC015566; AAH15566.1; -; mRNA.
DR   EMBL; M28286; AAA52285.1; -; Genomic_DNA.
DR   EMBL; M28284; AAA52285.1; JOINED; Genomic_DNA.
DR   EMBL; M28285; AAA52285.1; JOINED; Genomic_DNA.
DR   EMBL; M28293; AAA52286.1; -; Genomic_DNA.
DR   EMBL; M28287; AAA52286.1; JOINED; Genomic_DNA.
DR   EMBL; M35821; AAA52286.1; JOINED; Genomic_DNA.
DR   EMBL; M35822; AAA52286.1; JOINED; Genomic_DNA.
DR   EMBL; M28289; AAA52286.1; JOINED; Genomic_DNA.
DR   EMBL; M28290; AAA52286.1; JOINED; Genomic_DNA.
DR   EMBL; M28291; AAA52286.1; JOINED; Genomic_DNA.
DR   EMBL; M28292; AAA52286.1; JOINED; Genomic_DNA.
DR   EMBL; M27577; AAA58380.1; -; Genomic_DNA.
DR   EMBL; M27570; AAA58380.1; JOINED; Genomic_DNA.
DR   EMBL; M27573; AAA58380.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS12594.1; -. [P13637-1]
DR   CCDS; CCDS58663.1; -. [P13637-2]
DR   CCDS; CCDS58664.1; -. [P13637-3]
DR   PIR; S00801; S00801.
DR   RefSeq; NP_001243142.1; NM_001256213.1. [P13637-2]
DR   RefSeq; NP_001243143.1; NM_001256214.1. [P13637-3]
DR   RefSeq; NP_689509.1; NM_152296.4. [P13637-1]
DR   UniGene; Hs.515427; -.
DR   ProteinModelPortal; P13637; -.
DR   SMR; P13637; -.
DR   BioGrid; 106968; 37.
DR   IntAct; P13637; 6.
DR   MINT; MINT-2857038; -.
DR   STRING; 9606.ENSP00000302397; -.
DR   ChEMBL; CHEMBL2095186; -.
DR   TCDB; 3.A.3.1.1; the p-type atpase (p-atpase) superfamily.
DR   iPTMnet; P13637; -.
DR   PhosphoSitePlus; P13637; -.
DR   SwissPalm; P13637; -.
DR   BioMuta; ATP1A3; -.
DR   DMDM; 116241260; -.
DR   EPD; P13637; -.
DR   MaxQB; P13637; -.
DR   PaxDb; P13637; -.
DR   PeptideAtlas; P13637; -.
DR   PRIDE; P13637; -.
DR   Ensembl; ENST00000302102; ENSP00000302397; ENSG00000105409. [P13637-1]
DR   Ensembl; ENST00000543770; ENSP00000437577; ENSG00000105409. [P13637-2]
DR   Ensembl; ENST00000545399; ENSP00000444688; ENSG00000105409. [P13637-3]
DR   GeneID; 478; -.
DR   KEGG; hsa:478; -.
DR   UCSC; uc002osg.4; human. [P13637-1]
DR   CTD; 478; -.
DR   DisGeNET; 478; -.
DR   GeneCards; ATP1A3; -.
DR   GeneReviews; ATP1A3; -.
DR   HGNC; HGNC:801; ATP1A3.
DR   HPA; CAB033630; -.
DR   HPA; HPA045367; -.
DR   HPA; HPA056446; -.
DR   MalaCards; ATP1A3; -.
DR   MIM; 128235; phenotype.
DR   MIM; 182350; gene.
DR   MIM; 601338; phenotype.
DR   MIM; 614820; phenotype.
DR   neXtProt; NX_P13637; -.
DR   OpenTargets; ENSG00000105409; -.
DR   Orphanet; 2131; Alternating hemiplegia of childhood.
DR   Orphanet; 1171; Cerebellar ataxia - areflexia - pes cavus - optic atrophy - sensorineural hearing loss.
DR   Orphanet; 71517; Rapid-onset dystonia-parkinsonism.
DR   PharmGKB; PA64; -.
DR   eggNOG; KOG0203; Eukaryota.
DR   eggNOG; COG0474; LUCA.
DR   GeneTree; ENSGT00850000132256; -.
DR   HOGENOM; HOG000265622; -.
DR   HOVERGEN; HBG004298; -.
DR   InParanoid; P13637; -.
DR   KO; K01539; -.
DR   OrthoDB; EOG091G01BB; -.
DR   PhylomeDB; P13637; -.
DR   TreeFam; TF312838; -.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   Reactome; R-HSA-936837; Ion transport by P-type ATPases.
DR   ChiTaRS; ATP1A3; human.
DR   GeneWiki; ATP1A3; -.
DR   GenomeRNAi; 478; -.
DR   PRO; PR:P13637; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105409; -.
DR   CleanEx; HS_ATP1A3; -.
DR   ExpressionAtlas; P13637; baseline and differential.
DR   Genevisible; P13637; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0044327; C:dendritic spine head; IEA:Ensembl.
DR   GO; GO:0044326; C:dendritic spine neck; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:1903561; C:extracellular vesicle; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0042383; C:sarcolemma; IEA:Ensembl.
DR   GO; GO:0005890; C:sodium:potassium-exchanging ATPase complex; IDA:BHF-UCL.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; NAS:UniProtKB.
DR   GO; GO:0001540; F:beta-amyloid binding; IEA:Ensembl.
DR   GO; GO:0051087; F:chaperone binding; IPI:BHF-UCL.
DR   GO; GO:0031748; F:D1 dopamine receptor binding; IEA:Ensembl.
DR   GO; GO:0043395; F:heparan sulfate proteoglycan binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005391; F:sodium:potassium-exchanging ATPase activity; IDA:BHF-UCL.
DR   GO; GO:0086037; F:sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential; IEA:Ensembl.
DR   GO; GO:1990239; F:steroid hormone binding; NAS:BHF-UCL.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
DR   GO; GO:0060048; P:cardiac muscle contraction; IEA:Ensembl.
DR   GO; GO:0086064; P:cell communication by electrical coupling involved in cardiac conduction; TAS:BHF-UCL.
DR   GO; GO:0030007; P:cellular potassium ion homeostasis; IDA:BHF-UCL.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl.
DR   GO; GO:0071383; P:cellular response to steroid hormone stimulus; NAS:BHF-UCL.
DR   GO; GO:0097067; P:cellular response to thyroid hormone stimulus; IEA:Ensembl.
DR   GO; GO:0006883; P:cellular sodium ion homeostasis; IDA:BHF-UCL.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0010107; P:potassium ion import; IDA:BHF-UCL.
DR   GO; GO:1903779; P:regulation of cardiac conduction; TAS:Reactome.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:1903416; P:response to glycoside; NAS:BHF-UCL.
DR   GO; GO:0036376; P:sodium ion export from cell; IDA:BHF-UCL.
DR   GO; GO:0008542; P:visual learning; IEA:Ensembl.
DR   Gene3D; 1.20.1110.10; -; 2.
DR   Gene3D; 2.70.150.10; -; 1.
DR   Gene3D; 3.40.1110.10; -; 2.
DR   InterPro; IPR006068; ATPase_P-typ_cation-transptr_C.
DR   InterPro; IPR004014; ATPase_P-typ_cation-transptr_N.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_domN.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR023298; ATPase_P-typ_TM_dom.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR005775; P-type_ATPase_IIC.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   Pfam; PF00689; Cation_ATPase_C; 1.
DR   Pfam; PF00690; Cation_ATPase_N; 1.
DR   Pfam; PF00122; E1-E2_ATPase; 1.
DR   SMART; SM00831; Cation_ATPase_N; 1.
DR   SUPFAM; SSF56784; SSF56784; 3.
DR   SUPFAM; SSF81660; SSF81660; 1.
DR   TIGRFAMs; TIGR01106; ATPase-IIC_X-K; 1.
DR   TIGRFAMs; TIGR01494; ATPase_P-type; 2.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell membrane; Complete proteome;
KW   Deafness; Disease mutation; Dystonia; Hydrolase; Ion transport;
KW   Magnesium; Membrane; Metal-binding; Nucleotide-binding; Parkinsonism;
KW   Phosphoprotein; Potassium; Potassium transport; Reference proteome;
KW   Sodium; Sodium transport; Sodium/potassium transport; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1   1013       Sodium/potassium-transporting ATPase
FT                                subunit alpha-3.
FT                                /FTId=PRO_0000046298.
FT   TOPO_DOM      1     77       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     78     98       Helical. {ECO:0000255}.
FT   TOPO_DOM     99    121       Extracellular. {ECO:0000255}.
FT   TRANSMEM    122    142       Helical. {ECO:0000255}.
FT   TOPO_DOM    143    278       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    279    298       Helical. {ECO:0000255}.
FT   TOPO_DOM    299    310       Extracellular. {ECO:0000255}.
FT   TRANSMEM    311    328       Helical. {ECO:0000255}.
FT   TOPO_DOM    329    762       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    763    782       Helical. {ECO:0000255}.
FT   TOPO_DOM    783    792       Extracellular. {ECO:0000255}.
FT   TRANSMEM    793    813       Helical. {ECO:0000255}.
FT   TOPO_DOM    814    833       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    834    856       Helical. {ECO:0000255}.
FT   TOPO_DOM    857    908       Extracellular. {ECO:0000255}.
FT   TRANSMEM    909    928       Helical. {ECO:0000255}.
FT   TOPO_DOM    929    941       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    942    960       Helical. {ECO:0000255}.
FT   TOPO_DOM    961    975       Extracellular. {ECO:0000255}.
FT   TRANSMEM    976    996       Helical. {ECO:0000255}.
FT   TOPO_DOM    997   1013       Cytoplasmic. {ECO:0000255}.
FT   REGION       72     74       Interaction with phosphoinositide-3
FT                                kinase. {ECO:0000250}.
FT   ACT_SITE    366    366       4-aspartylphosphate intermediate.
FT                                {ECO:0000250}.
FT   METAL       707    707       Magnesium. {ECO:0000250}.
FT   METAL       711    711       Magnesium. {ECO:0000250}.
FT   MOD_RES      37     37       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P06687}.
FT   MOD_RES      56     56       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6PIC6}.
FT   MOD_RES     218    218       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6PIC6}.
FT   MOD_RES     265    265       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6PIC6}.
FT   MOD_RES     442    442       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P06687}.
FT   MOD_RES     548    548       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q6PIC6}.
FT   MOD_RES     580    580       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P50993}.
FT   MOD_RES     665    665       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6PIE5}.
FT   MOD_RES     819    819       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P09626}.
FT   MOD_RES     933    933       Phosphoserine; by PKA. {ECO:0000250}.
FT   VAR_SEQ       1      2       MG -> MGGWEEERNRRAT (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046956.
FT   VAR_SEQ       1      2       MG -> MGSGGSDSYRIATSQ (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046957.
FT   VARIANT     137    137       S -> F (in AHC2; dbSNP:rs542652468).
FT                                {ECO:0000269|PubMed:22842232}.
FT                                /FTId=VAR_068935.
FT   VARIANT     137    137       S -> Y (in AHC2; dbSNP:rs542652468).
FT                                {ECO:0000269|PubMed:22842232}.
FT                                /FTId=VAR_068936.
FT   VARIANT     140    140       Q -> L (in AHC2; dbSNP:rs606231427).
FT                                {ECO:0000269|PubMed:22842232}.
FT                                /FTId=VAR_068937.
FT   VARIANT     220    220       D -> N (in AHC2).
FT                                {ECO:0000269|PubMed:22842232}.
FT                                /FTId=VAR_068938.
FT   VARIANT     274    274       I -> N (in AHC2; dbSNP:rs80356532).
FT                                {ECO:0000269|PubMed:22842232,
FT                                ECO:0000269|PubMed:22850527}.
FT                                /FTId=VAR_068939.
FT   VARIANT     274    274       I -> T (in DYT12; dbSNP:rs80356532).
FT                                {ECO:0000269|PubMed:15260953}.
FT                                /FTId=VAR_026735.
FT   VARIANT     277    277       E -> K (in DYT12; dbSNP:rs80356533).
FT                                {ECO:0000269|PubMed:15260953}.
FT                                /FTId=VAR_026736.
FT   VARIANT     322    322       V -> D (in AHC2; dbSNP:rs606231428).
FT                                {ECO:0000269|PubMed:22850527}.
FT                                /FTId=VAR_070767.
FT   VARIANT     333    333       C -> F (in AHC2; dbSNP:rs606231430).
FT                                {ECO:0000269|PubMed:22842232}.
FT                                /FTId=VAR_068940.
FT   VARIANT     371    371       L -> P (in AHC2; dbSNP:rs606231433).
FT                                {ECO:0000269|PubMed:22850527}.
FT                                /FTId=VAR_070768.
FT   VARIANT     613    613       T -> M (in DYT12; dbSNP:rs80356534).
FT                                {ECO:0000269|PubMed:15260953}.
FT                                /FTId=VAR_026737.
FT   VARIANT     755    755       G -> C (in AHC2; dbSNP:rs557052809).
FT                                {ECO:0000269|PubMed:22850527,
FT                                ECO:0000269|PubMed:23409136}.
FT                                /FTId=VAR_070769.
FT   VARIANT     755    755       G -> S (in AHC2; dbSNP:rs557052809).
FT                                {ECO:0000269|PubMed:22842232}.
FT                                /FTId=VAR_068941.
FT   VARIANT     758    758       I -> S (in DYT12; dbSNP:rs80356535).
FT                                {ECO:0000269|PubMed:15260953}.
FT                                /FTId=VAR_026738.
FT   VARIANT     772    772       S -> R (in AHC2; dbSNP:rs534926223).
FT                                {ECO:0000269|PubMed:22850527}.
FT                                /FTId=VAR_070770.
FT   VARIANT     773    773       N -> I (in AHC2; dbSNP:rs606231437).
FT                                {ECO:0000269|PubMed:22850527}.
FT                                /FTId=VAR_070771.
FT   VARIANT     773    773       N -> S (in AHC2; dbSNP:rs606231437).
FT                                {ECO:0000269|PubMed:22842232}.
FT                                /FTId=VAR_068942.
FT   VARIANT     780    780       F -> L (in DYT12; dbSNP:rs80356536).
FT                                {ECO:0000269|PubMed:15260953}.
FT                                /FTId=VAR_026739.
FT   VARIANT     801    801       D -> N (in AHC2; protein levels is
FT                                similar to wild-type but the enzyme
FT                                activity is significantly decreased;
FT                                dbSNP:rs80356537).
FT                                {ECO:0000269|PubMed:22842232,
FT                                ECO:0000269|PubMed:22850527,
FT                                ECO:0000269|PubMed:23409136}.
FT                                /FTId=VAR_068943.
FT   VARIANT     801    801       D -> Y (in DYT12; dbSNP:rs80356537).
FT                                {ECO:0000269|PubMed:15260953}.
FT                                /FTId=VAR_026740.
FT   VARIANT     806    806       M -> R (in AHC2; dbSNP:rs549006436).
FT                                {ECO:0000269|PubMed:22842232}.
FT                                /FTId=VAR_068944.
FT   VARIANT     810    810       I -> S (in AHC2; dbSNP:rs536681257).
FT                                {ECO:0000269|PubMed:22842232}.
FT                                /FTId=VAR_068945.
FT   VARIANT     811    811       S -> P (in AHC2; protein levels is
FT                                similar to wild-type but the enzyme
FT                                activity is significantly decreased;
FT                                dbSNP:rs387907282).
FT                                {ECO:0000269|PubMed:22842232}.
FT                                /FTId=VAR_068946.
FT   VARIANT     815    815       E -> K (in AHC2; protein levels is
FT                                similar to wild-type but the enzyme
FT                                activity is significantly decreased;
FT                                dbSNP:rs387907281).
FT                                {ECO:0000269|PubMed:22842232,
FT                                ECO:0000269|PubMed:22850527,
FT                                ECO:0000269|PubMed:23409136}.
FT                                /FTId=VAR_068947.
FT   VARIANT     818    818       E -> K (in CAPOS; dbSNP:rs587777771).
FT                                {ECO:0000269|PubMed:24468074}.
FT                                /FTId=VAR_070772.
FT   VARIANT     919    919       Missing (in AHC2).
FT                                {ECO:0000269|PubMed:22842232}.
FT                                /FTId=VAR_068948.
FT   VARIANT     923    923       D -> N (in DYT12; dbSNP:rs267606670).
FT                                {ECO:0000269|PubMed:19652145}.
FT                                /FTId=VAR_068949.
FT   VARIANT     923    923       D -> Y (in AHC2; dbSNP:rs267606670).
FT                                {ECO:0000269|PubMed:22850527}.
FT                                /FTId=VAR_070773.
FT   VARIANT     927    927       C -> Y (in AHC2; dbSNP:rs606231444).
FT                                /FTId=VAR_070774.
FT   VARIANT     947    947       G -> R (in AHC2; dbSNP:rs398122887).
FT                                {ECO:0000269|PubMed:22842232}.
FT                                /FTId=VAR_068950.
FT   VARIANT     955    955       A -> D (in AHC2; dbSNP:rs606231446).
FT                                {ECO:0000269|PubMed:22842232}.
FT                                /FTId=VAR_068951.
FT   VARIANT     992    992       D -> Y (in AHC2; dbSNP:rs606231447).
FT                                {ECO:0000269|PubMed:22842232}.
FT                                /FTId=VAR_068952.
FT   VARIANT    1013   1013       Y -> YY (in DYT12; there is a drastic 40-
FT                                to 50-fold reduction in Na(+) affinity in
FT                                the mutant protein).
FT                                {ECO:0000269|PubMed:19351654}.
FT                                /FTId=VAR_068953.
FT   CONFLICT      1      2       MG -> MEIH (in Ref. 2; CAA31390).
FT                                {ECO:0000305}.
FT   CONFLICT    144    144       S -> R (in Ref. 3; BAH12387).
FT                                {ECO:0000305}.
FT   CONFLICT    336    336       L -> V (in Ref. 1; AAA51798, 2; CAA31390,
FT                                6; AAA52285 and 8; AAA58380).
FT                                {ECO:0000305}.
FT   CONFLICT    380    380       H -> T (in Ref. 6; AAA52285).
FT                                {ECO:0000305}.
FT   CONFLICT    421    421       A -> P (in Ref. 8; AAA58380).
FT                                {ECO:0000305}.
FT   CONFLICT    430    430       I -> M (in Ref. 2; CAA31390).
FT                                {ECO:0000305}.
FT   CONFLICT    555    557       FPK -> YPQ (in Ref. 1; AAA51798, 2;
FT                                CAA31390 and 6; AAA52286). {ECO:0000305}.
FT   CONFLICT    577    577       G -> P (in Ref. 1; AAA51798).
FT                                {ECO:0000305}.
FT   CONFLICT    583    583       D -> G (in Ref. 1; AAA51798, 2; CAA31390
FT                                and 6; AAA52286). {ECO:0000305}.
FT   CONFLICT    919    919       V -> A (in Ref. 6; AAA52286).
FT                                {ECO:0000305}.
FT   CONFLICT    944    944       L -> M (in Ref. 6; AAA52286).
FT                                {ECO:0000305}.
FT   CONFLICT    982    982       F -> S (in Ref. 2; CAA31390).
FT                                {ECO:0000305}.
FT   CONFLICT   1006   1006       W -> S (in Ref. 1; AAA51798).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1013 AA;  111749 MW;  BF28CD9F1E11AF48 CRC64;
     MGDKKDDKDS PKKNKGKERR DLDDLKKEVA MTEHKMSVEE VCRKYNTDCV QGLTHSKAQE
     ILARDGPNAL TPPPTTPEWV KFCRQLFGGF SILLWIGAIL CFLAYGIQAG TEDDPSGDNL
     YLGIVLAAVV IITGCFSYYQ EAKSSKIMES FKNMVPQQAL VIREGEKMQV NAEEVVVGDL
     VEIKGGDRVP ADLRIISAHG CKVDNSSLTG ESEPQTRSPD CTHDNPLETR NITFFSTNCV
     EGTARGVVVA TGDRTVMGRI ATLASGLEVG KTPIAIEIEH FIQLITGVAV FLGVSFFILS
     LILGYTWLEA VIFLIGIIVA NVPEGLLATV TVCLTLTAKR MARKNCLVKN LEAVETLGST
     STICSDKTGT LTQNRMTVAH MWFDNQIHEA DTTEDQSGTS FDKSSHTWVA LSHIAGLCNR
     AVFKGGQDNI PVLKRDVAGD ASESALLKCI ELSSGSVKLM RERNKKVAEI PFNSTNKYQL
     SIHETEDPND NRYLLVMKGA PERILDRCST ILLQGKEQPL DEEMKEAFQN AYLELGGLGE
     RVLGFCHYYL PEEQFPKGFA FDCDDVNFTT DNLCFVGLMS MIDPPRAAVP DAVGKCRSAG
     IKVIMVTGDH PITAKAIAKG VGIISEGNET VEDIAARLNI PVSQVNPRDA KACVIHGTDL
     KDFTSEQIDE ILQNHTEIVF ARTSPQQKLI IVEGCQRQGA IVAVTGDGVN DSPALKKADI
     GVAMGIAGSD VSKQAADMIL LDDNFASIVT GVEEGRLIFD NLKKSIAYTL TSNIPEITPF
     LLFIMANIPL PLGTITILCI DLGTDMVPAI SLAYEAAESD IMKRQPRNPR TDKLVNERLI
     SMAYGQIGMI QALGGFFSYF VILAENGFLP GNLVGIRLNW DDRTVNDLED SYGQQWTYEQ
     RKVVEFTCHT AFFVSIVVVQ WADLIICKTR RNSVFQQGMK NKILIFGLFE ETALAAFLSY
     CPGMDVALRM YPLKPSWWFC AFPYSFLIFV YDEIRKLILR RNPGGWVEKE TYY
//
